- Monthly option
- $157.91 on the checked page
- Quantity
- 5 mL listed; concentration needs confirmation
- Quarterly option
- Savings message is not a complete invoice
The monthly selection is the clearest comparison point
Trava's sermorelin product page lists a monthly option at $157.91. It also promotes a quarterly package using a savings statement. We treat those as two pieces of commercial information rather than assuming that the quarterly savings amount is itself a monthly price or the full package charge. The selected invoice should resolve the longer-term option.
The provider markets online clinical evaluation followed by prescription fulfillment when appropriate. Its broader catalog contains other compounds and routes, but their quantities and prices do not define this sermorelin service. This profile connects to an individual injection review so the provider-level description and the actual product specifications remain easy to distinguish.
A volume label does not finish the comparison
The sermorelin page gives a 5 mL quantity. That establishes a volume label but not a complete amount of active ingredient without concentration. Two preparations can have the same volume while containing different total quantities. Readers should obtain the concentration and pharmacy label before attempting any amount-based price comparison.
The term monthly is also a commercial description, not a self-contained use instruction. The clinician and pharmacist should explain the actual preparation, supply period and handling requirements. We have not obtained the product or independently inspected a label, so this publication does not fill the missing concentration or derive an administration schedule from the bottle volume.
Determine what the care arrangement includes
Ask whether the selected quote covers the initial review, delivery, necessary supplies and ongoing clinical access. Clarify any required laboratory work and who pays for it. The product page's price is useful, but a comparison of total care costs needs the services surrounding the prescription as well as the medication itself.
Before choosing a longer package, request the initial payment, renewal dates and cancellation conditions in writing. A quarterly saving may change the upfront commitment, and a subscription cancellation may only stop later orders. Neither a savings headline nor a monthly selector establishes whether an already dispensed preparation can be returned or unused supply refunded.
The compounding disclosure belongs in the assessment
Trava discloses that compounded medications are not FDA-approved. That status remains relevant even when the product is prescribed after a professional evaluation. Ask which pharmacy prepares the medication and what evidence supports the intended use, keeping product-quality questions separate from the broader question of whether treatment is clinically appropriate.
Our review does not verify Trava's marketed wellness outcomes or rank its treatment as clinically superior. The strongest documented features for comparison are the visible monthly amount, a stated volume and the presence of a longer-package option. The incomplete concentration, full quarterly invoice and individualized care requirements should be resolved before those commercial details are treated as a complete decision.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.